M. Lichinitser

4.3k citations
23 papers · 1.3k · 1 hit paper · h-index 12

Impact in

  • Oncology top 5%
    • Colorectal Cancer Treatments and Studies
    • Cancer Immunotherapy and Biomarkers
    • Cancer Treatment and Pharmacology
    • Gastrointestinal Tumor Research and Treatment

Papers in

    • Cancer Treatment and Pharmacology 7
    • Colorectal Cancer Treatments and Studies 5
    • HER2/EGFR in Cancer Research 5
    • Bone health and treatments 4
    • Cutaneous Melanoma Detection and Management 3

M. Lichinitser

23 papers receiving 1.2k citations

M. Lichinitser's Hit Papers

Phase III, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300 2018 · 372 citations
3720+2+5Years since publication100200300

Peers

M. Lichinitser
Comparison fields: 5 of 68
  • Oncology 677
  • Gastroenterology 119
  • Anesthesiology and Pain Medicine 89
  • Surgery 623
  • Pulmonary and Respiratory Medicine 403
Replace Hsiang‐Lin Tsai with:
Hsiang‐Lin Tsai Taiwan
Céline Lepère France
Chung‐Wei Fan Taiwan
Ian D. Schnadig United States
Chi‐Young Jeong South Korea
Yuichiro Miki Japan
Krsto Kolarić United States
Ta-Sen Yeh Taiwan
Peter Grimminger Germany
Judith Karner‐Hanusch Austria
M. Lichinitser relative to Hsiang‐Lin Tsai Taiwan Hsiang‐Lin Tsai's profile →
Citations per field
00.5×6.3×
Hsiang‐Lin Tsai · 1×
Citations per year

Countries citing papers authored by M. Lichinitser

Since Specialization
Citations

This map shows the geographic impact of M. Lichinitser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Lichinitser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Lichinitser more than expected).

Fields of papers citing papers by M. Lichinitser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Lichinitser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Lichinitser. The network helps show where M. Lichinitser may publish in the future.

Co-authors

The 25 scholars most cited alongside M. Lichinitser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. Lichinitser Line = papers co-authored together M. Lichinitser links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase III, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300
Hit paper breakdown →
2018372
2 2003367
3 2002115
4 200783
5 200763
6 201555
7 200250
8 201036
9 200932
10 201129
11 201813
12 200413
13 200511
14 20079
15 20118
16 20065
17 20045
18 20145
19 20114
20 20073

About M. Lichinitser

M. Lichinitser is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Cancer Research and Surgery, having authored 23 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (7 papers), Colorectal Cancer Treatments and Studies (5 papers), HER2/EGFR in Cancer Research (5 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Bone health and treatments (4 papers), Cutaneous Melanoma Detection and Management (3 papers), Breast Cancer Treatment Studies (2 papers) and Economic and Financial Impacts of Cancer (2 papers). The work is most often cited by research in Oncology (677 citations), Gastroenterology (119 citations), Anesthesiology and Pain Medicine (89 citations), Surgery (623 citations) and Pulmonary and Respiratory Medicine (403 citations). M. Lichinitser has collaborated with scholars based in United States, Belgium and Russia. Frequent co-authors include Giuseppe Tonini, Christian Peschel, Matti Aapro, H. P. Sleeboom, J. Mezger, Roberto Labianca, Richard J. Gralla, A. Macciocchi, S. van der Vegt and Narikazu Boku. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Cancer and Cancer Cell International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact